Human ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis

Stem Cell Reports

Volumn 3, Issue 1, 2014, Pages 115-130

  Wang, Xiaofang ^a,b   Kimbrel, Erin A ^c   Ijichi, Kumiko ^a   Paul, Debayon ^a   Lazorchak, Adam S ^b   Chu, Jianlin ^c   Kouris, Nicholas A ^c   Yavanian, Gregory J ^c   Lu, Shi Jiang ^c   Pachter, Joel S ^a   Crocker, Stephen J ^a   Lanza, Robert ^c   Xu, Ren He ^a,b,d  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b ImStem Biotechnology Inc   (United States)

^c Advanced Cell Technology   (United States)

^d University of Macau   (Macao)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 6; MYELIN; PHYTOHEMAGGLUTININ;

ADIPOCYTE; ALLERGIC ENCEPHALOMYELITIS; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BONE MARROW CELL; BONE MARROW MESENCHYMAL STEM CELL; CARTILAGE CELL; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CROSS REACTION; CYTOKINE RELEASE; CYTOLOGY; DEMYELINATION; DISEASE MODEL; DISEASE SEVERITY; EMBRYONIC STEM CELL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LUMBAR SPINAL CORD; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MALIGNANT TRANSFORMATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; MOUSE; MULTIPLE SCLEROSIS; NEUROFILAMENT; NONHUMAN; OSTEOCYTE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; THERAPY; TIGHT JUNCTION;

ANIMALS; BONE MARROW CELLS; CENTRAL NERVOUS SYSTEM; CYTOLOGY; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MULTIPLE SCLEROSIS; PATHOLOGY; THERAPY;

EID: 84904152341     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2014.04.020     Document Type: Article

References (57)

1. J.J. Auletta, A.M. Bartholomew, R.T. Maziarz, R.J. Deans, R.H. Miller, H.M. Lazarus, and J.A. Cohen The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis Immunotherapy 4 2012 529 547
2. L. Bai, D.P. Lennon, V. Eaton, K. Maier, A.I. Caplan, S.D. Miller, and R.H. Miller Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis Glia 57 2009 1192 1203
3. T. Barberi, L.M. Willis, N.D. Socci, and L. Studer Derivation of multipotent mesenchymal precursors from human embryonic stem cells PLoS Med. 2 2005 e161
4. S. Barlow, G. Brooke, K. Chatterjee, G. Price, R. Pelekanos, T. Rossetti, M. Doody, D. Venter, S. Pain, K. Gilshenan, and K. Atkinson Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells Stem Cells Dev. 17 2008 1095 1107
5. S.E. Brown, W. Tong, and P.H. Krebsbach The derivation of mesenchymal stem cells from human embryonic stem cells Cells Tissues Organs (Print) 189 2009 256 260
6. F. Carrión, E. Nova, P. Luz, F. Apablaza, and F. Figueroa Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation Immunol. Lett. 135 2011 10 16
7. Y.X. Chao, B.P. He, and S.S. Tay Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease J. Neuroimmunol. 216 2009 39 50
8. P. Connick, M. Kolappan, C. Crawley, D.J. Webber, R. Patani, A.W. Michell, M.Q. Du, S.L. Luan, D.R. Altmann, and A.J. Thompson et al. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study Lancet Neurol. 11 2012 150 156
9. M. Costa, M. Dottori, E. Ng, S.M. Hawes, K. Sourris, P. Jamshidi, M.F. Pera, A.G. Elefanty, and E.G. Stanley The hESC line Envy expresses high levels of GFP in all differentiated progeny Nat. Methods 2 2005 259 260 (Pubitemid 41131006)
10. P.J. Darlington, M.N. Boivin, C. Renoux, M. François, J. Galipeau, M.S. Freedman, H.L. Atkins, J.A. Cohen, L. Solchaga, and A. Bar-Or Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis Ann. Neurol. 68 2010 540 545
11. A. De Becker, P. Van Hummelen, M. Bakkus, I. Vande Broek, J. De Wever, M. De Waele, and I. Van Riet Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3 Haematologica 92 2007 440 449 (Pubitemid 350144289)
12. O. Dienz, and M. Rincon The effects of IL-6 on CD4 T cell responses Clin. Immunol. 130 2009 27 33
13. F. Djouad, P. Plence, C. Bony, P. Tropel, F. Apparailly, J. Sany, D. Noël, and C. Jorgensen Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals Blood 102 2003 3837 3844 (Pubitemid 37409409)
14. K. Gijbels, S. Brocke, J.S. Abrams, and L. Steinman Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation Mol. Med. 1 1995 795 805 (Pubitemid 3013088)
15. M. Giuliani, M. Fleury, A. Vernochet, F. Ketroussi, D. Clay, B. Azzarone, J.J. Lataillade, and A. Durrbach Long-lasting inhibitory effects of fetal liver mesenchymal stem cells on T-lymphocyte proliferation PLoS ONE 6 2011 e19988
16. D. Gordon, G. Pavlovska, C.P. Glover, J.B. Uney, D. Wraith, and N.J. Scolding Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration Neurosci. Lett. 448 2008 71 73
17. D. Gordon, G. Pavlovska, J.B. Uney, D.C. Wraith, and N.J. Scolding Human mesenchymal stem cells infiltrate the spinal cord, reduce demyelination, and localize to white matter lesions in experimental autoimmune encephalomyelitis J. Neuropathol. Exp. Neurol. 69 2010 1087 1095
18. W. Gruenloh, A. Kambal, C. Sondergaard, J. McGee, C. Nacey, S. Kalomoiris, K. Pepper, S. Olson, F. Fierro, and J.A. Nolta Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells Tissue Eng. Part A 17 2011 1517 1525
19. C.P. Hofstetter, E.J. Schwarz, D. Hess, J. Widenfalk, A. El Manira, D.J. Prockop, and L. Olson Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery Proc. Natl. Acad. Sci. USA 99 2002 2199 2204 (Pubitemid 34169038)
20. N.S. Hwang, S. Varghese, H.J. Lee, Z. Zhang, Z. Ye, J. Bae, L. Cheng, and J. Elisseeff In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells Proc. Natl. Acad. Sci. USA 105 2008 20641 20646
21. D. Karussis, C. Karageorgiou, A. Vaknin-Dembinsky, B. Gowda-Kurkalli, J.M. Gomori, I. Kassis, J.W. Bulte, P. Petrou, T. Ben-Hur, O. Abramsky, and S. Slavin Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis Arch. Neurol. 67 2010 1187 1194
22. E.A. Kimbrel, N.A. Kouris, G.J. Yavanian, J. Chu, Y. Qin, A. Chan, R.P. Singh, D. McCurdy, L. Gordon, R.D. Levinson, and R. Lanza Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties Stem Cells Dev. 2014
23. I. Klimanskaya, Y. Chung, S. Becker, S.J. Lu, and R. Lanza Human embryonic stem cell lines derived from single blastomeres Nature 444 2006 481 485 (Pubitemid 44809064)
24. C. Kyriakou, N. Rabin, A. Pizzey, A. Nathwani, and K. Yong Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model Haematologica 93 2008 1457 1465
25. M.M. Lalu, L. McIntyre, C. Pugliese, D. Fergusson, B.W. Winston, J.C. Marshall, J. Granton, D.J. Stewart Canadian Critical Care Trials Group Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials PLoS ONE 7 2012 e47559
26. T.V. Lanz, S. Becker, M. Osswald, S. Bittner, M.K. Schuhmann, C.A. Opitz, S. Gaikwad, B. Wiestler, U.M. Litzenburger, and F. Sahm et al. Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis Proc. Natl. Acad. Sci. USA 110 2013 14735 14740
27. V. Lazarevic, X. Chen, J.H. Shim, E.S. Hwang, E. Jang, A.N. Bolm, M. Oukka, V.K. Kuchroo, and L.H. Glimcher T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt Nat. Immunol. 12 2011 96 104
28. H.J. Lee, J.K. Lee, H. Lee, J.E. Carter, J.W. Chang, W. Oh, Y.S. Yang, J.G. Suh, B.H. Lee, H.K. Jin, and J.S. Bae Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation Neurobiol. Aging 33 2012 588 602
29. M.D. Leech, T.A. Barr, D.G. Turner, S. Brown, R.A. O'Connor, D. Gray, R.J. Mellanby, and S.M. Anderton Cutting edge: IL-6-dependent autoimmune disease: dendritic cells as a sufficient, but transient, source J. Immunol. 190 2013 881 885
30. S.J. Lu, Q. Feng, S. Caballero, Y. Chen, M.A. Moore, M.B. Grant, and R. Lanza Generation of functional hemangioblasts from human embryonic stem cells Nat. Methods 4 2007 501 509 (Pubitemid 46852076)
31. H.F. McFarland, and R. Martin Multiple sclerosis: a complicated picture of autoimmunity Nat. Immunol. 8 2007 913 919 (Pubitemid 47300005)
32. M. Mohyeddin Bonab, S. Yazdanbakhsh, J. Lotfi, K. Alimoghaddom, F. Talebian, F. Hooshmand, A. Ghavamzadeh, and B. Nikbin Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study Iran. J. Immunol. 4 2007 50 57 (Pubitemid 46799666)
33. E.N. Olivier, A.C. Rybicki, and E.E. Bouhassira Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells Stem Cells 24 2006 1914 1922 (Pubitemid 44474167)
34. T. Owens, I. Bechmann, and B. Engelhardt Perivascular spaces and the two steps to neuroinflammation J. Neuropathol. Exp. Neurol. 67 2008 1113 1121
35. A.K. Patanella, M. Zinno, D. Quaranta, V. Nociti, G. Frisullo, G. Gainotti, P.A. Tonali, A.P. Batocchi, and C. Marra Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients J. Neurosci. Res. 88 2010 1106 1112
36. D. Paul, A.E. Cowan, S. Ge, and J.S. Pachter Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels Microvasc. Res. 86 2013 1 10
37. D. Paul, S. Ge, Y. Lemire, E.R. Jellison, D.R. Serwanski, N.H. Ruddle, and J.S. Pachter Cell-selective knockout and 3D confocal image analysis reveals separate roles for astrocyte-and endothelial-derived CCL2 in neuroinflammation J. Neuroinflammation 11 2014 10
38. N.L. Payne, G. Sun, C. McDonald, D. Layton, L. Moussa, A. Emerson-Webber, N. Veron, C. Siatskas, D. Herszfeld, J. Price, and C.C. Bernard Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination Cell Transplant. 22 2013 1409 1425
39. J.P. Peron, T. Jazedje, W.N. Brandão, P.M. Perin, M. Maluf, L.P. Evangelista, S. Halpern, M.G. Nisenbaum, C.E. Czeresnia, and M. Zatz et al. Human endometrial-derived mesenchymal stem cells suppress inflammation in the central nervous system of EAE mice Stem Cell Rev. 8 2012 940 952
40. M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, J.D. Mosca, M.A. Moorman, D.W. Simonetti, S. Craig, and D.R. Marshak Multilineage potential of adult human mesenchymal stem cells Science 284 1999 143 147 (Pubitemid 29282067)
41. M.G. Pomper, H. Hammond, X. Yu, Z. Ye, C.A. Foss, D.D. Lin, J.J. Fox, and L. Cheng Serial imaging of human embryonic stem-cell engraftment and teratoma formation in live mouse models Cell Res. 19 2009 370 379
42. A. Quintana, M. Müller, R.F. Frausto, R. Ramos, D.R. Getts, E. Sanz, M.J. Hofer, M. Krauthausen, N.J. King, J. Hidalgo, and I.L. Campbell Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis J. Immunol. 183 2009 2079 2088
43. W.J. Rombouts, and R.E. Ploemacher Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture Leukemia 17 2003 160 170 (Pubitemid 36175902)
44. H. Samuelsson, O. Ringdén, H. Lönnies, and K. Le Blanc Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells Cytotherapy 11 2009 129 136
45. L. Sánchez, I. Gutierrez-Aranda, G. Ligero, R. Rubio, M. Muñoz-López, J.L. García-Pérez, V. Ramos, P.J. Real, C. Bueno, and R. Rodríguez et al. Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease Stem Cells 29 2011 251 262
46. A.M. Sheikh, A. Nagai, K. Wakabayashi, D. Narantuya, S. Kobayashi, S. Yamaguchi, and S.U. Kim Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: contribution of fractalkine and IL-5 Neurobiol. Dis. 41 2011 717 724
47. I.M. Stromnes, and J.M. Goverman Active induction of experimental allergic encephalomyelitis Nat. Protoc. 1 2006 1810 1819 (Pubitemid 46773300)
48. G.S. Teo, J.A. Ankrum, R. Martinelli, S.E. Boetto, K. Simms, T.E. Sciuto, A.M. Dvorak, J.M. Karp, and C.V. Carman Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-α-activated endothelial cells via both leukocyte-like and novel mechanisms Stem Cells 30 2012 2472 2486
49. J.A. Thomson, J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, V.S. Marshall, and J.M. Jones Embryonic stem cell lines derived from human blastocysts Science 282 1998 1145 1147 (Pubitemid 28516247)
50. A. Uccelli, and D.J. Prockop Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Curr. Opin. Immunol. 22 2010 768 774
51. M.A. Vodyanik, J. Yu, X. Zhang, S. Tian, R. Stewart, J.A. Thomson, and I.I. Slukvin A mesoderm-derived precursor for mesenchymal stem and endothelial cells Cell Stem Cell 7 2010 718 729
52. X. Wang, G. Lin, K. Martins-Taylor, H. Zeng, and R.H. Xu Inhibition of caspase-mediated anoikis is critical for basic fibroblast growth factor-sustained culture of human pluripotent stem cells J. Biol. Chem. 284 2009 34054 34064
53. M.S. Weber, T. Menge, K. Lehmann-Horn, H.C. Kronsbein, U. Zettl, J. Sellner, B. Hemmer, and O. Stüve Current treatment strategies for multiple sclerosis - efficacy versus neurological adverse effects Curr. Pharm. Des. 18 2012 209 219
54. R.S. Wong Mesenchymal stem cells: angels or demons? J. Biomed. Biotechnol. 2011 2011 459510
55. B. Yamout, R. Hourani, H. Salti, W. Barada, T. El-Hajj, A. Al-Kutoubi, A. Herlopian, E.K. Baz, R. Mahfouz, and R. Khalil-Hamdan et al. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study J. Neuroimmunol. 227 2010 185 189
56. E. Zappia, S. Casazza, E. Pedemonte, F. Benvenuto, I. Bonanni, E. Gerdoni, D. Giunti, A. Ceravolo, F. Cazzanti, and F. Frassoni et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy Blood 106 2005 1755 1761 (Pubitemid 41208591)
57. J. Zhang, Y. Li, J. Chen, Y. Cui, M. Lu, S.B. Elias, J.B. Mitchell, L. Hammill, P. Vanguri, and M. Chopp Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice Exp. Neurol. 195 2005 16 26 (Pubitemid 41116810)